Roohi Mariam Peter

Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.

The biopharma industry is always in need of talented minds to take promising pipelines to the clinic and beyond.

We reached out to VCs to nominate prominent founders in the industry who are committed to bringing potentially life-changing treatments to market.

Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.

G protein-coupled receptors (GPCRs) are the largest and most diverse group of membrane receptors in the body.

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic fibrosis.

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest report.

A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region.

Newsletter Signup - Under Article / In Page " indicates required fields Subscribe to our newsletter to get the latest biotech news!